Trial · NCT03504397
Results by group4,598
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 4,598
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression Free Survival (PFS) | mFOLFOX6 + Zolbetuximab | 11.04 | 95% Confidence Interval 9.69 to 12.52 | Months | |
| Progression Free Survival (PFS) | mFOLFOX6+ Placebo | 8.94 | 95% Confidence Interval 8.21 to 10.41 | Months | |
| Overall Survival (OS) | mFOLFOX6 + Zolbetuximab | 18.23 | 95% Confidence Interval 16.13 to 20.63 | Months | |
| Overall Survival (OS) | mFOLFOX6+ Placebo | 15.57 | 95% Confidence Interval 13.67 to 16.92 | Months | |
Time to Confirmed Deterioration (TTCD) Using Physical Functioning (PF) as Measured by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core Questionnaire (EORTC QLQ-C30) | mFOLFOX6 + Zolbetuximab | 9.89 | 95% Confidence Interval 6.01 to NA | Months | |
Time to Confirmed Deterioration (TTCD) Using Physical Functioning (PF) as Measured by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core Questionnaire (EORTC QLQ-C30) | mFOLFOX6+ Placebo | 12.32 | 95% Confidence Interval 9.26 to NA | Months | |
| Time to Confirmed Deterioration (TTCD) Using Oesophago-gastric Questionnaire (OG25) on Abdominal Pain and Discomfort as Measured by EORTC QLQ-OG25 | mFOLFOX6 + Zolbetuximab | NA | 95% Confidence Interval NA to NA | Months | |
| Time to Confirmed Deterioration (TTCD) Using Oesophago-gastric Questionnaire (OG25) on Abdominal Pain and Discomfort as Measured by EORTC QLQ-OG25 | mFOLFOX6+ Placebo | NA | 95% Confidence Interval 15.67 to NA | Months | |
| Time to Confirmed Deterioration (TTCD) Using Global Health Status as Measured by EORTC QLQ-C30 | mFOLFOX6 + Zolbetuximab | 15.44 | 95% Confidence Interval 7.06 to 23.89 | Months | |
| Time to Confirmed Deterioration (TTCD) Using Global Health Status as Measured by EORTC QLQ-C30 | mFOLFOX6+ Placebo | 11.83 | 95% Confidence Interval 9.23 to 15.08 | Months | |
| Objective Response Rate (ORR) | mFOLFOX6 + Zolbetuximab | 48.1 | 95% Confidence Interval 42.11 to 54.05 | Percentage of participants | |
| Objective Response Rate (ORR) | mFOLFOX6+ Placebo | 47.5 | 95% Confidence Interval 41.56 to 53.52 | Percentage of participants | |
| Duration Of Response (DOR) | mFOLFOX6 + Zolbetuximab | 9.00 | 95% Confidence Interval 7.49 to 10.38 | Months | |
| Duration Of Response (DOR) | mFOLFOX6+ Placebo | 8.11 | 95% Confidence Interval 6.47 to 11.37 | Months | |
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) | mFOLFOX6 + Zolbetuximab | 278 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) | mFOLFOX6+ Placebo | 277 | Participants | ||
| Number of Participants With Eastern Cooperative Oncology Group (ECOG) Performance Status | mFOLFOX6 + Zolbetuximab | Baseline Score 0 | 125 | Participants | |
| Number of Participants With Eastern Cooperative Oncology Group (ECOG) Performance Status | mFOLFOX6+ Placebo | Baseline Score 0 | 115 | Participants | |
| Number of Participants With Eastern Cooperative Oncology Group (ECOG) Performance Status | mFOLFOX6 + Zolbetuximab | Baseline Score 1 | 153 | Participants | |
| Number of Participants With Eastern Cooperative Oncology Group (ECOG) Performance Status | mFOLFOX6+ Placebo | Baseline Score 1 | 163 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03504397/results